Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERGER F. M. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. J Pharmacol Exp Ther. 1954 Dec;112(4):413–423. [PubMed] [Google Scholar]
- BORRUS J. C. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states. J Am Med Assoc. 1955 Apr 30;157(18):1596–1598. doi: 10.1001/jama.1955.02950350010005. [DOI] [PubMed] [Google Scholar]
- DAVIES D. L., SHEPHERD M. Reserpine in the treatment of anxious and depressed patients. Lancet. 1955 Jul 16;269(6881):117–120. doi: 10.1016/s0140-6736(55)92118-8. [DOI] [PubMed] [Google Scholar]
- FERNANDES DA FONSECA A., WEST E. D. Controlled trial of meprobamate. Br Med J. 1956 Nov 24;2(5003):1206–1209. doi: 10.1136/bmj.2.5003.1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOLKSON A. Use of meprobamate in tension states. J Ment Sci. 1957 Oct;103(433):860–863. doi: 10.1192/bjp.103.433.860. [DOI] [PubMed] [Google Scholar]
- HELLER G. C., WALTON D., BLACK D. A. Meprobamate in the treatment of tension states. J Ment Sci. 1957 Jul;103(432):581–588. doi: 10.1192/bjp.103.432.581. [DOI] [PubMed] [Google Scholar]
- SELLING L. S. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate). J Am Med Assoc. 1955 Apr 30;157(18):1594–1596. doi: 10.1001/jama.1955.02950350008004. [DOI] [PubMed] [Google Scholar]